Revenue, last quarter
$794.7K
+206.7% vs same quarter last year
Net income
$270.1K
+351.2% vs same quarter last year
EPS, diluted
-
Operating cash flow
$59.7K
−64.5% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $1.9M | $896.2K |
| FY24 | $323.9K | −$1.3M |
| FY23 | $551.5K | −$971.9K |
| FY22 | $621.6K | −$809.7K |
| FY21 | $888K | −$647.6K |
| FY20 | $958.7K | −$595.8K |
| FY19 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 75.3% | 47.4% | 47.2% |
| FY24 | 67% | −141.8% | −404% |
| FY23 | 50.3% | −62.7% | −176.2% |
| FY22 | 52.8% | −82.2% | −130.3% |
| FY21 | 33.6% | −96.6% | −72.9% |
| FY20 | 23.7% | −86.8% | −62.2% |
| FY19 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | −$1M |
| FY22 | −$707K |
| FY21 | −$1.4M |
| FY20 | −$740.1K |
| FY19 | - |
- Bio Essence
- Healthcare median
Show the numbers
| Year | Bio Essence | Healthcare median |
|---|---|---|
| FY25 | 47.2% | −40.6% |
| FY24 | −404% | −60.7% |
| FY23 | −176.2% | −97.1% |
| FY22 | −130.3% | −128.5% |
| FY21 | −72.9% | −129.2% |
| FY20 | −62.2% | −136.5% |
| FY19 | - | −133.7% |
News
No stories filed under Bio Essence yet - coverage appears here as the news feed clusters it.